Congress trades
Covetrus, Inc. (CVET)
About Covetrus, Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Chief executive
- Benjamin Wolin
- Employees
- 4,035
- Listed since
- Feb 4, 2019
- Market value
- -
- Price to earnings
- -
- Earnings per share
- -$0.63
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 2, 2022| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2022reported Aug 4, 2022 | $0.25 | $0.25 | $1.2B | n/a | EPS in lineRevenue n/a |
| Q1 FY2022reported May 5, 2022 | $0.25 | $0.22 | $1.1B | $1.2B | EPS beatRevenue in line |
| Q4 FY2021reported Feb 24, 2022 | $0.26 | $0.25 | $1.1B | $1.1B | EPS beatRevenue in line |
| Q3 FY2021reported Nov 4, 2021 | $0.23 | $0.23 | $1.2B | $1.2B | EPS in lineRevenue in line |
| Q2 FY2021reported Aug 5, 2021 | $0.26 | $0.24 | $1.2B | $1.2B | EPS beatRevenue beat |
| Q1 FY2021reported May 6, 2021 | $0.21 | $0.17 | $1.1B | $1.1B | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in CVET
13 disclosures of 13 on record · median 28d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +0.5%S&P -8.6% · vs S&P 500 +9.2% | Sep 15, 2022 | Oct 16, 2022 | 31d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +29.3%S&P -19.9% · vs S&P 500 +49.2% | Apr 19, 2022 | May 16, 2022 | 27d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +31.0%S&P -16.4% · vs S&P 500 +47.4% | Mar 15, 2022 | Apr 17, 2022 | 33d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +6.3%S&P -20.3% · vs S&P 500 +26.6% | Oct 18, 2021 | Nov 15, 2021 | 28d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +6.7%S&P -20.4% · vs S&P 500 +27.2% | Sep 15, 2021 | Oct 13, 2021 | 28d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -33.3%S&P -3.0% · vs S&P 500 -30.3% | Dec 23, 2020 | Jan 11, 2021 | 19d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | -21.4%S&P +2.7% · vs S&P 500 -24.1% | Oct 16, 2020 | Nov 5, 2020 | 20d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +6.8%S&P +4.8% · vs S&P 500 +2.0% | Sep 15, 2020 | Oct 13, 2020 | 28d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | -3.5%S&P +4.0% · vs S&P 500 -7.5% | Aug 24, 2020 | Sep 20, 2020 | 27d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | -6.5%S&P +5.7% · vs S&P 500 -12.2% | Aug 12, 2020 | Sep 20, 2020 | 39d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -9.9%S&P -0.3% · vs S&P 500 -9.6% | Sep 2, 2020 | Sep 14, 2020 | 12d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -7.9%S&P +5.5% · vs S&P 500 -13.4% | Aug 17, 2020 | Sep 14, 2020 | 28d |
| Susan M. CollinsSpouse | Stock | Sale (Full) | $1,001 - $15,000 | +38.8%S&P +25.4% · vs S&P 500 +13.5% | Aug 15, 2019 | Sep 10, 2019 | 26d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 6, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded CVET?
Josh Gottheimer, Gilbert Ray Cisneros, Jr., Susan M. Collins disclosed CVET transactions in the filings shown here.
How quickly are CVET trades disclosed?
Congressional disclosures took a median of 28 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.